BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
kimia biosciences limited stock

KIMIA BIOSCIENCES LIMITED Share Price

48.28 -1.42 (-2.85%)
Dec 13 2024 03:25 PM Pharmaceuticals NSE: KIMIABL

KIMIA BIOSCIENCES LIMITED Share Price Update

As of the latest trading session, KIMIA BIOSCIENCES LIMITED share price is currently at 48.28, which is down by -1.42 from its previous closing. Today, the stock has fluctuated between 47.00 and 50.49. Over the past year, KIMIA BIOSCIENCES LIMITED has achieved a return of 26.80 %. In the last month alone, the return has been 1.40 %. Read More...

KIMIA BIOSCIENCES LIMITED Performance

Day Range

Low47.00 High50.49
47.54

52 Week Range

Low 33.20 High 58.40
47.54

KIMIA BIOSCIENCES LIMITED Share Price

530313

KIMIABL

img img img img
No Data Available

Open Price

50.49

Prev. Close

49.70

Volume (Shares)

3975.00

Total traded value

1.92

Upper Circuit

59.64

Lower Circuit

39.76

Note: The current prices & values are delayed, Login to your account for live updates.

KIMIA BIOSCIENCES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 224.90
PE Ratio (TTM) 77.93
Book Value / Share 0.71
Beta 0.60
ROE 0.00%
EPS (TTM) 0.61
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.61

KIMIA BIOSCIENCES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 28.18
Operating Expense 26.64
Net Profit 1.61
Net Profit Margin (%) 5.71
Earnings Per Share (EPS) 0.34
EBITDA 3.74
Effective Tax Rate (%) 15.70
Particulars JUN 2024 (Values in Cr)
Revenue 22.40
Operating Expense 20.70
Net Profit 1.44
Net Profit Margin (%) 6.42
Earnings Per Share (EPS) 0.30
EBITDA 3.79
Effective Tax Rate (%) 19.66
Particulars MAR 2024 (Values in Cr)
Revenue 30.30
Operating Expense 28.30
Net Profit 1.80
Net Profit Margin (%) 5.94
Earnings Per Share (EPS) 0.38
EBITDA 4.47
Effective Tax Rate (%) 22.07
Particulars DEC 2023 (Values in Cr)
Revenue 26.14
Operating Expense 29.32
Net Profit -1.95
Net Profit Margin (%) -7.45
Earnings Per Share (EPS) -0.41
EBITDA -0.47
Effective Tax Rate (%) 25.00
Particulars SEP 2023 (Values in Cr)
Revenue 24.20
Operating Expense 28.10
Net Profit -2.44
Net Profit Margin (%) -10.08
Earnings Per Share (EPS) -0.52
EBITDA -1.33
Effective Tax Rate (%) 25.07
Particulars MAR 2024 (Values in Cr)
Revenue 104.88
Operating Expense 113.70
Net Profit -5.31
Net Profit Margin (%) -5.06
Earnings Per Share (EPS) -1.12
EBITDA 1.16
Effective Tax Rate (%) 26.18
Particulars MAR 2023 (Values in Cr)
Revenue 128.52
Operating Expense 141.07
Net Profit -9.35
Net Profit Margin (%) -7.27
Earnings Per Share (EPS) -1.98
EBITDA -4.81
Effective Tax Rate (%) 24.53
Particulars MAR 2022 (Values in Cr)
Revenue 124.90
Operating Expense 130.85
Net Profit -3.70
Net Profit Margin (%) -2.96
Earnings Per Share (EPS) -0.78
EBITDA 1.56
Effective Tax Rate (%) 26.29
Particulars MAR 2021 (Values in Cr)
Revenue 132.71
Operating Expense 129.64
Net Profit 5.10
Net Profit Margin (%) 3.84
Earnings Per Share (EPS) 1.08
EBITDA 10.83
Effective Tax Rate (%) 7.77
Particulars MAR 2020 (Values in Cr)
Revenue 106.29
Operating Expense 106.03
Net Profit 1.38
Net Profit Margin (%) 1.29
Earnings Per Share (EPS) 0.32
EBITDA 5.42
Effective Tax Rate (%) -13.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 4.60
EBITDA Margin -3.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.15
ROE % -22.20
ROCE % -2.03
Total Debt to Total Equity 2.57
EBITDA Margin 1.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.90
ROE % 32.16
ROCE % 13.88
Total Debt to Total Equity 2.48
EBITDA Margin 8.17
Particulars MAR 2020 (Values in Cr)
Book Value / Share 2.86
ROE % 14.73
ROCE % 7.65
Total Debt to Total Equity 3.31
EBITDA Margin 5.10
Particulars MAR 2019 (Values in Cr)
Book Value / Share 2.39
ROE % 79.42
ROCE % 14.46
Total Debt to Total Equity 7.63
EBITDA Margin 7.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.49
Total Assets 121.31
Total Liabilities 121.31
Total Equity 5.46
Share Outstanding 47312741
Price to Book Ratio 28.26
Return on Assets (%) -7.70
Return on Capital (%) -16.02
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 109.49
Total Liabilities 109.49
Total Equity 14.88
Share Outstanding 47312741
Price to Book Ratio 11.94
Return on Assets (%) -3.38
Return on Capital (%) -6.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.67
Total Assets 106.66
Total Liabilities 106.66
Total Equity 18.43
Share Outstanding 47312741
Price to Book Ratio 9.73
Return on Assets (%) 4.78
Return on Capital (%) 8.06
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 85.66
Total Liabilities 85.66
Total Equity 13.37
Share Outstanding 46353951
Price to Book Ratio 6.99
Return on Assets (%) 1.61
Return on Capital (%) 3.14
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.26
Total Assets 65.39
Total Liabilities 65.39
Total Equity 6.10
Share Outstanding 14594420
Price to Book Ratio 14.87
Return on Assets (%) 5.89
Return on Capital (%) 10.82
Particulars MAR 2023 (Values in Cr)
Net Income -12.38
Cash from Operations -6.78
Cash from Investing -2.79
Cash from Financing 9.54
Net change in Cash -0.02
Free Cash Flow -3.97
Particulars MAR 2022 (Values in Cr)
Net Income -5.01
Cash from Operations 8.06
Cash from Investing -0.71
Cash from Financing -7.66
Net change in Cash -0.38
Free Cash Flow 11.64
Particulars MAR 2021 (Values in Cr)
Net Income 5.53
Cash from Operations 5.92
Cash from Investing -13.60
Cash from Financing 7.99
Net change in Cash 0.35
Free Cash Flow 19.48
Particulars MAR 2020 (Values in Cr)
Net Income 1.22
Cash from Operations 0.23
Cash from Investing -8.62
Cash from Financing 8.45
Net change in Cash 0.13
Free Cash Flow 9.24
Particulars MAR 2019 (Values in Cr)
Net Income 3.80
Cash from Operations -2.49
Cash from Investing -2.22
Cash from Financing 4.41
Net change in Cash -0.45
Free Cash Flow 0.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2254.45 47.63 22.83 38191.74 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 48.70
  • 26 Days 48.40
  • 10 Days 48.60
  • 50 Days 48.60
  • 12 Days 48.70
  • 100 Days 49.50
  • 20 Days 48.20
  • 200 Days 39.90
49.84
PIVOT
First Resistance 50.85
Second Resistance 52.00
Third Resistance 53.01
First Support 48.69
Second Support 47.68
Third Support 46.53
RSI 46.53
MACD 0.29
Commodity Channel Index (CCI) 18.96
ADX 16.63
Williams % R -64.70

Over 1 Month

down

1.40

Over 3 Months

down

-7.63

Over 6 Months

down

-15.33

Over 1 Year

down

26.80

Over 3 Years

down

5.83

Over 5 Years

down

17.09

KIMIA BIOSCIENCES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KIMIA BIOSCIENCES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
24.67
Promoter Holdings
74.93
FII
0.0
DII
0.38
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sameer Goel Shareholding of Promoter and Promoter Group 3.5455776E7 74.94
Rahul Agrawal Public Shareholding 2050000.0 4.33
Anish Kumar Aggarwal Public Shareholding 2050000.0 4.33
Manish Gupta Public Shareholding 2009820.0 4.25
Roma Mittal Public Shareholding 1942288.0 4.11
Vipul Goel Shareholding of Promoter and Promoter Group 16.0 0.0
Vandana Goel Shareholding of Promoter and Promoter Group 16.0 0.0
Santosh Goel Shareholding of Promoter and Promoter Group 32.0 0.0

KIMIA BIOSCIENCES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KIMIA BIOSCIENCES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KIMIA BIOSCIENCES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Kimia Biosciences Ltd?

Answer Field

The share price of Kimia Biosciences Ltd for NSE is ₹ 0.00 and for BSE is ₹ 47.54.

What is the Market Cap of Kimia Biosciences Ltd?

Answer Field

The market cap of Kimia Biosciences Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,24.90 Cr. as of now.

What is the 52 Week High and Low of Kimia Biosciences Ltd?

Answer Field

The 52 Week High and Low of Kimia Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 58.40 and ₹ 33.20.

How to Buy Kimia Biosciences Ltd share?

Answer Field

You can trade in Kimia Biosciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kimia Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been 26.80%.

What is the Current Share Price of Kimia Biosciences Ltd?

Answer Field

Kimia Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 47.54 as on Dec 13 2024 03:25 PM.

What is the Market Cap of Kimia Biosciences Ltd Share?

Answer Field

The market cap of Kimia Biosciences Ltd for NSE ₹ 0.0 & for BSE ₹ 2,24.90 as on Dec 13 2024 03:25 PM.

What is the P/E Ratio of Kimia Biosciences Ltd Share?

Answer Field

As on Dec 13 2024 03:25 PM the price-to-earnings (PE) ratio for Kimia Biosciences Ltd share is 77.93.

What is the PB ratio of Kimia Biosciences Ltd Share?

Answer Field

As on Dec 13 2024 03:25 PM, the price-to-book (PB) ratio for Kimia Biosciences Ltd share is 0.71.

How to Buy Kimia Biosciences Ltd Share?

Answer Field

You can trade in Kimia Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kimia Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Kimia Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kimia Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader